Literature DB >> 14609996

Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.

Paul M Ridker1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609996     DOI: 10.1161/01.CIR.0000100688.17280.E6

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  87 in total

Review 1.  Inflammation in atherosclerosis and diabetes mellitus.

Authors:  Jorge Plutzky
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

Review 2.  Relationship of C-reactive protein, metabolic syndrome and diabetes mellitus: potential role of statins.

Authors:  David T Nash
Journal:  J Natl Med Assoc       Date:  2005-12       Impact factor: 1.798

Review 3.  Blood biologic markers of stroke: improved management, reduced cost?

Authors:  Alison E Baird
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

4.  Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins.

Authors:  J Igarashi; M Miyoshi; T Hashimoto; Y Kubota; H Kosaka
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

5.  Missed opportunities for the secondary prevention of cardiovascular disease in Canada.

Authors:  Daniel G Hackam; Lawrence A Leiter; Andrew T Yan; Raymond T Yan; Aurora Mendelsohn; Mary Tan; Louis Zavodni; Richard Chen; Jennifer L Tsang; Anjali Kundi; Peter J Lin; David H Fitchett; Anatoly Langer; Shaun G Goodman
Journal:  Can J Cardiol       Date:  2007-12       Impact factor: 5.223

Review 6.  Residual risk in statin-treated patients: future therapeutic options.

Authors:  Catherine Y Campbell; Juan J Rivera; Roger S Blumenthal
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

Review 7.  Biomarkers of atherosclerosis: clinical applications.

Authors:  Todd M Brown; Vera Bittner
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

Review 8.  Cardiac disease in chronic obstructive pulmonary disease.

Authors:  Jeremy A Falk; Steven Kadiev; Gerard J Criner; Steven M Scharf; Omar A Minai; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

9.  C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.

Authors:  Paul M Ridker; Nina P Paynter; Nader Rifai; J Michael Gaziano; Nancy R Cook
Journal:  Circulation       Date:  2008-11-09       Impact factor: 29.690

10.  Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Emil M DeGoma; Benjamin French; Richard L Dunbar; Matthew A Allison; Emile R Mohler; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2012-07-20       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.